Computational Epigenetics and Diseases - cover

Computational Epigenetics and Diseases

Loo Keat Wei

  • 06 februari 2019
  • 9780128145142
Wil ik lezen
  • Wil ik lezen
  • Aan het lezen
  • Gelezen
  • Verwijderen

Samenvatting:

Computational Epigenetics and Diseases, written by leading scientists in this evolving field, provides a comprehensive and cutting-edge knowledge of computational epigenetics in human diseases. In particular, the major computational tools, databases, and strategies for computational epigenetics analysis, for example, DNA methylation, histone modifications, microRNA, noncoding RNA, and ceRNA, are summarized, in the context of human diseases.

This book discusses bioinformatics methods for epigenetic analysis specifically applied to human conditions such as aging, atherosclerosis, diabetes mellitus, schizophrenia, bipolar disorder, Alzheimer disease, Parkinson disease, liver and autoimmune disorders, and reproductive and respiratory diseases. Additionally, different organ cancers, such as breast, lung, and colon, are discussed.

This book is a valuable source for graduate students and researchers in genetics and bioinformatics, and several biomedical field members interested in applying computational epigenetics in their research.

  • Provides a comprehensive and cutting-edge knowledge of computational epigenetics in human diseases
  • Summarizes the major computational tools, databases, and strategies for computational epigenetics analysis, such as DNA methylation, histone modifications, microRNA, noncoding RNA, and ceRNA
  • Covers the major milestones and future directions of computational epigenetics in various kinds of human diseases such as aging, atherosclerosis, diabetes, heart disease, neurological disorders, cancers, blood disorders, liver diseases, reproductive diseases, respiratory diseases, autoimmune diseases, human imprinting disorders, and infectious diseases

We gebruiken cookies om er zeker van te zijn dat je onze website zo goed mogelijk beleeft. Als je deze website blijft gebruiken gaan we ervan uit dat je dat goed vindt. Ok